Live feed16:05:00·30dPRReleasevia QuantisnowNorthStrive Biosciences Signs Licensing Agreement Amendment with MOA Life Plus [KOSDAQ: 142760] for Dual Myostatin Assets Targeting Muscle Preservation in Combination with GLP-1 TreatmentsByQuantisnow·Wall Street's wire, on your screen.ELAB· PMGC Holdings Inc.Health Care